pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
A Phase 1a/b Study Investigating the Safety for Advanced, or metastatic solid t…
Phase 1 · other · Advanced, or metastatic solid tumors with methylthioadenosine phosphorylase (MTAP) homozygous deletion and/or lost MTAP protein expression
A Phase 1a/b Study Investigating the Safety for Advanced, or metastatic solid t… for Advanced, or metastatic solid tumors with methylthioadenosine phosphorylase (MTAP) homozygous deletion and/or lost MTAP protein expression is a Phase 1 program (other) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BEONE MEDICINES AUS PTY LTD
- Phase
- Phase 1
- Modality
- other
- Indication
- Advanced, or metastatic solid tumors with methylthioadenosine phosphorylase (MTAP) homozygous deletion and/or lost MTAP protein expression
- Status
- active
- Trials
- 1